Use of riociguat as front-line therapy in a patient with high-risk pulmonary arterial hypertension and right ventricular failure.

1 September 2024 (14:00 - 14:15)
Organised by: Logo
Congress Presentation Part of: Pulmonary hypertension (2) Clinical ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology